Načítá se...
Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct ligated rats and human hepatic cells
Cholestasis leads to liver cell death, fibrosis, cirrhosis, and eventually liver failure. Despite limited benefits, ursodeoxycholic acid (UDCA) is the only FDA approved treatment for cholestatic disorders. Retinoic acid (RA) is a ligand for nuclear receptors, which modulate bile salt homeostasis. RA...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069505/ https://ncbi.nlm.nih.gov/pubmed/21274875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24047 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|